SeaStar Medical Holding (ICU) Stock Analysis

What SeaStar Medical Holding does

SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals. The company specializes in developing and commercializing extracorporeal therapies that specifically target the immune 'effector cells' responsible for driving systemic inflammation, a process that directly harms tissues and releases a cascade of pro-inflammatory cytokines, thereby initiating and perpetuating dysregulated immune reactions. Its product pipeline spans various critical care areas, including acute kidney injury (both pediatric and adult) requiring continuous renal replacement therapy (CRRT), cardiorenal syndrome in patients with congestive heart failure (including those with or without LVADs), myocardial stunning in end-stage renal disease, and hepatorenal syndrome. The firm maintains its headquarters in Denver, Colorado.

Key metrics

ETFs linked to ICU

Broad-market and Healthcare sector ETFs an investor holding SeaStar Medical Holding is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how ICU fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for SeaStar Medical Holding?

SeaStar Medical Holding trades under the ticker ICU on NASDAQ.

Which exchange is ICU listed on?

ICU is listed on NASDAQ.

What sector does SeaStar Medical Holding operate in?

SeaStar Medical Holding is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ICU in a portfolio?

PortView shows ICU's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.